Position in HLN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,044,698
+$252,697 QoQ
Shares Held
111,972
+41.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#137
of 639 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GUGGENHEIM CAPITAL LLC holds $54,489,807 across 19 Drug Manufacturers - Specialty & Generic names. HLN ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
353,321 | $25,389,646 | |
| 2 | VTRS |
Viatris Inc
|
558,340 | $8,866,437 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
27,212 | $4,586,310 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
6,346 | $3,438,452 | |
| 5 | LQDA |
Liquidia Corp
|
30,801 | $2,455,763 | |
| 6 | ALKS |
Alkermes plc.
|
32,738 | $1,715,471 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
100,140 | $1,451,027 | |
| 8 | HLN |
Haleon plc
This page
|
111,972 | $1,044,698 |
All Filings in HLN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,044,698 | 111,972 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $792,001 | 79,121 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $695,719 | 68,815 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $668,614 | 74,539 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $687,779 | 66,324 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $600,204 | 58,329 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $642,594 | 67,358 | Shares | Defined | 2025-02-13 | |
| 2022-12-31 | $95,240 | 11,905 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $119,120 | 19,560 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||